Global Biological Hemostatic Material Market Research Report 2024(Status and Outlook)

Global Biological Hemostatic Material Market Research Report 2024(Status and Outlook)



Report Overview:

Biological hemostatic agents are active agents that work to provide hemostasis by activating clotting factors in the final stages of the coagulation cascade. Thrombin is activated by calcium and as noted previously acts to convert fibrinogen to fibrin, stabilizing the clot.

The Global Biological Hemostatic Material Market Size was estimated at USD 564.16 million in 2023 and is projected to reach USD 800.28 million by 2029, exhibiting a CAGR of 6.00% during the forecast period.

This report provides a deep insight into the global Biological Hemostatic Material market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biological Hemostatic Material Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biological Hemostatic Material market in any manner.

Global Biological Hemostatic Material Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Johnson & Johnson

BD

Baxter

B.Braun

Cura Medical

GELITA MEDICAL

Curasan AG

Meril Life Sciences

Zhonghui Shengxi

Beijing Datsing Bio-tech

Guizhou Jin Jiu Biotech

Beijing Taikesiman

Foryou Medical

Saikesaisi Holdings Group

Biotemed

Hangzhou Singclean Medical Products

Market Segmentation (by Type)

Collagen

Gelatin

Polysaccharides

Other

Market Segmentation (by Application)

Hospital

Clinic

Other

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Biological Hemostatic Material Market
  • Overview of the regional outlook of the Biological Hemostatic Material Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biological Hemostatic Material Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Biological Hemostatic Material
1.2 Key Market Segments
1.2.1 Biological Hemostatic Material Segment by Type
1.2.2 Biological Hemostatic Material Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Biological Hemostatic Material Market Overview
2.1 Global Market Overview
2.1.1 Global Biological Hemostatic Material Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Biological Hemostatic Material Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Biological Hemostatic Material Market Competitive Landscape
3.1 Global Biological Hemostatic Material Sales by Manufacturers (2019-2024)
3.2 Global Biological Hemostatic Material Revenue Market Share by Manufacturers (2019-2024)
3.3 Biological Hemostatic Material Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Biological Hemostatic Material Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Biological Hemostatic Material Sales Sites, Area Served, Product Type
3.6 Biological Hemostatic Material Market Competitive Situation and Trends
3.6.1 Biological Hemostatic Material Market Concentration Rate
3.6.2 Global 5 and 10 Largest Biological Hemostatic Material Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Biological Hemostatic Material Industry Chain Analysis
4.1 Biological Hemostatic Material Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Biological Hemostatic Material Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Biological Hemostatic Material Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biological Hemostatic Material Sales Market Share by Type (2019-2024)
6.3 Global Biological Hemostatic Material Market Size Market Share by Type (2019-2024)
6.4 Global Biological Hemostatic Material Price by Type (2019-2024)
7 Biological Hemostatic Material Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biological Hemostatic Material Market Sales by Application (2019-2024)
7.3 Global Biological Hemostatic Material Market Size (M USD) by Application (2019-2024)
7.4 Global Biological Hemostatic Material Sales Growth Rate by Application (2019-2024)
8 Biological Hemostatic Material Market Segmentation by Region
8.1 Global Biological Hemostatic Material Sales by Region
8.1.1 Global Biological Hemostatic Material Sales by Region
8.1.2 Global Biological Hemostatic Material Sales Market Share by Region
8.2 North America
8.2.1 North America Biological Hemostatic Material Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biological Hemostatic Material Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Biological Hemostatic Material Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biological Hemostatic Material Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biological Hemostatic Material Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Johnson and Johnson
9.1.1 Johnson and Johnson Biological Hemostatic Material Basic Information
9.1.2 Johnson and Johnson Biological Hemostatic Material Product Overview
9.1.3 Johnson and Johnson Biological Hemostatic Material Product Market Performance
9.1.4 Johnson and Johnson Business Overview
9.1.5 Johnson and Johnson Biological Hemostatic Material SWOT Analysis
9.1.6 Johnson and Johnson Recent Developments
9.2 BD
9.2.1 BD Biological Hemostatic Material Basic Information
9.2.2 BD Biological Hemostatic Material Product Overview
9.2.3 BD Biological Hemostatic Material Product Market Performance
9.2.4 BD Business Overview
9.2.5 BD Biological Hemostatic Material SWOT Analysis
9.2.6 BD Recent Developments
9.3 Baxter
9.3.1 Baxter Biological Hemostatic Material Basic Information
9.3.2 Baxter Biological Hemostatic Material Product Overview
9.3.3 Baxter Biological Hemostatic Material Product Market Performance
9.3.4 Baxter Biological Hemostatic Material SWOT Analysis
9.3.5 Baxter Business Overview
9.3.6 Baxter Recent Developments
9.4 B.Braun
9.4.1 B.Braun Biological Hemostatic Material Basic Information
9.4.2 B.Braun Biological Hemostatic Material Product Overview
9.4.3 B.Braun Biological Hemostatic Material Product Market Performance
9.4.4 B.Braun Business Overview
9.4.5 B.Braun Recent Developments
9.5 Cura Medical
9.5.1 Cura Medical Biological Hemostatic Material Basic Information
9.5.2 Cura Medical Biological Hemostatic Material Product Overview
9.5.3 Cura Medical Biological Hemostatic Material Product Market Performance
9.5.4 Cura Medical Business Overview
9.5.5 Cura Medical Recent Developments
9.6 GELITA MEDICAL
9.6.1 GELITA MEDICAL Biological Hemostatic Material Basic Information
9.6.2 GELITA MEDICAL Biological Hemostatic Material Product Overview
9.6.3 GELITA MEDICAL Biological Hemostatic Material Product Market Performance
9.6.4 GELITA MEDICAL Business Overview
9.6.5 GELITA MEDICAL Recent Developments
9.7 Curasan AG
9.7.1 Curasan AG Biological Hemostatic Material Basic Information
9.7.2 Curasan AG Biological Hemostatic Material Product Overview
9.7.3 Curasan AG Biological Hemostatic Material Product Market Performance
9.7.4 Curasan AG Business Overview
9.7.5 Curasan AG Recent Developments
9.8 Meril Life Sciences
9.8.1 Meril Life Sciences Biological Hemostatic Material Basic Information
9.8.2 Meril Life Sciences Biological Hemostatic Material Product Overview
9.8.3 Meril Life Sciences Biological Hemostatic Material Product Market Performance
9.8.4 Meril Life Sciences Business Overview
9.8.5 Meril Life Sciences Recent Developments
9.9 Zhonghui Shengxi
9.9.1 Zhonghui Shengxi Biological Hemostatic Material Basic Information
9.9.2 Zhonghui Shengxi Biological Hemostatic Material Product Overview
9.9.3 Zhonghui Shengxi Biological Hemostatic Material Product Market Performance
9.9.4 Zhonghui Shengxi Business Overview
9.9.5 Zhonghui Shengxi Recent Developments
9.10 Beijing Datsing Bio-tech
9.10.1 Beijing Datsing Bio-tech Biological Hemostatic Material Basic Information
9.10.2 Beijing Datsing Bio-tech Biological Hemostatic Material Product Overview
9.10.3 Beijing Datsing Bio-tech Biological Hemostatic Material Product Market Performance
9.10.4 Beijing Datsing Bio-tech Business Overview
9.10.5 Beijing Datsing Bio-tech Recent Developments
9.11 Guizhou Jin Jiu Biotech
9.11.1 Guizhou Jin Jiu Biotech Biological Hemostatic Material Basic Information
9.11.2 Guizhou Jin Jiu Biotech Biological Hemostatic Material Product Overview
9.11.3 Guizhou Jin Jiu Biotech Biological Hemostatic Material Product Market Performance
9.11.4 Guizhou Jin Jiu Biotech Business Overview
9.11.5 Guizhou Jin Jiu Biotech Recent Developments
9.12 Beijing Taikesiman
9.12.1 Beijing Taikesiman Biological Hemostatic Material Basic Information
9.12.2 Beijing Taikesiman Biological Hemostatic Material Product Overview
9.12.3 Beijing Taikesiman Biological Hemostatic Material Product Market Performance
9.12.4 Beijing Taikesiman Business Overview
9.12.5 Beijing Taikesiman Recent Developments
9.13 Foryou Medical
9.13.1 Foryou Medical Biological Hemostatic Material Basic Information
9.13.2 Foryou Medical Biological Hemostatic Material Product Overview
9.13.3 Foryou Medical Biological Hemostatic Material Product Market Performance
9.13.4 Foryou Medical Business Overview
9.13.5 Foryou Medical Recent Developments
9.14 Saikesaisi Holdings Group
9.14.1 Saikesaisi Holdings Group Biological Hemostatic Material Basic Information
9.14.2 Saikesaisi Holdings Group Biological Hemostatic Material Product Overview
9.14.3 Saikesaisi Holdings Group Biological Hemostatic Material Product Market Performance
9.14.4 Saikesaisi Holdings Group Business Overview
9.14.5 Saikesaisi Holdings Group Recent Developments
9.15 Biotemed
9.15.1 Biotemed Biological Hemostatic Material Basic Information
9.15.2 Biotemed Biological Hemostatic Material Product Overview
9.15.3 Biotemed Biological Hemostatic Material Product Market Performance
9.15.4 Biotemed Business Overview
9.15.5 Biotemed Recent Developments
9.16 Hangzhou Singclean Medical Products
9.16.1 Hangzhou Singclean Medical Products Biological Hemostatic Material Basic Information
9.16.2 Hangzhou Singclean Medical Products Biological Hemostatic Material Product Overview
9.16.3 Hangzhou Singclean Medical Products Biological Hemostatic Material Product Market Performance
9.16.4 Hangzhou Singclean Medical Products Business Overview
9.16.5 Hangzhou Singclean Medical Products Recent Developments
10 Biological Hemostatic Material Market Forecast by Region
10.1 Global Biological Hemostatic Material Market Size Forecast
10.2 Global Biological Hemostatic Material Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Biological Hemostatic Material Market Size Forecast by Country
10.2.3 Asia Pacific Biological Hemostatic Material Market Size Forecast by Region
10.2.4 South America Biological Hemostatic Material Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Biological Hemostatic Material by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Biological Hemostatic Material Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Biological Hemostatic Material by Type (2025-2030)
11.1.2 Global Biological Hemostatic Material Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Biological Hemostatic Material by Type (2025-2030)
11.2 Global Biological Hemostatic Material Market Forecast by Application (2025-2030)
11.2.1 Global Biological Hemostatic Material Sales (K Units) Forecast by Application
11.2.2 Global Biological Hemostatic Material Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings